| Nonalcoholic fatty liver disease: current therapies and future perspectives in drug delivery I Domingues, IA Leclercq, A Beloqui Journal of Controlled Release 363, 415-434, 2023 | 9 | 2023 |
| A nanoparticle platform for combined mucosal healing and immunomodulation in inflammatory bowel disease treatment V Marotti, Y Xu, CB Michalowski, W Zhang, I Domingues, H Ameraoui, ... Bioactive materials 32, 206-221, 2024 | 4 | 2024 |
| Exploiting the biological effect exerted by lipid nanocapsules in non-alcoholic fatty liver disease I Domingues, CB Michalowski, V Marotti, W Zhang, M Van Hul, PD Cani, ... Journal of Controlled Release 356, 542-553, 2023 | 3 | 2023 |
| “Green” synthesized versus chemically synthesized zinc oxide nanoparticles: In vivo antihyperglycemic activity and pharmacokinetics EK Kambale, I Domingues, W Zhang, V Marotti, C Chen, K Hughes, ... International journal of pharmaceutics 650, 123701, 2024 | 2 | 2024 |
| Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease I Domingues, H Yagoubi, W Zhang, V Marotti, EK Kambale, K Vints, ... Drug Delivery and Translational Research, 1-13, 2024 | | 2024 |
| Resistência aos Antibióticos em Infeções Adquiridas na Comunidade IL Domingues Resistência aos Antibióticos em Infeções Adquiridas na Comunidade, 2020 | | 2020 |
| An in Situ Bioadhesive Foam as a Large Intestinal Delivery Platform for Macromolecules to Treat Inflammatory Bowel Disease W Zhang, F McCartney, Y Xu, C Bohns Michalowski, I Domingues, ... Available at SSRN 4733798, 0 | | |
